Cargando…

Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study

OBJECTIVES: To evaluate and compare efficacy and tolerability of Vilazodone with Escitalopram and Amitriptyline in patients of major depressive disorder(MDD). METHODS: This was a randomized, prospective, parallel-group, open label clinical study in which newly diagnosed patients of MDD were randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadam, Renuka L., Sontakke, Smita Dipak, Tiple, Prashant, Motghare, Vijay M., Bajait, Chaitali S., Kalikar, Mrunalini V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282684/ https://www.ncbi.nlm.nih.gov/pubmed/32565594 http://dx.doi.org/10.4103/ijp.IJP_441_18

Ejemplares similares

Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study
por: Kalikar, Mrunalini, et al.
Publicado: (2017)

Assessment of adherence to medication during chronic illnesses in pregnancy
por: Sontakke, Smita, et al.
Publicado: (2021)

Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial
por: Shinde, Viraj Ashok, et al.
Publicado: (2017)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
por: Sinha, Vishakha V., et al.
Publicado: (2023)

An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2022)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

Evaluation of adherence to therapy in patients of chronic kidney disease
por: Sontakke, Smita, et al.
Publicado: (2015)

A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study
por: Urade, Chetan S., et al.
Publicado: (2015)

Different Endocrine Effects of an Evening Dose of Amitriptyline, Escitalopram, and Placebo in Healthy Participants
por: Frase, Lukas, et al.
Publicado: (2018)

Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders
por: Bajait, Chaitali S, et al.
Publicado: (2014)

Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study
por: Dakhale, Ganesh N., et al.
Publicado: (2019)

Assessment of quality of life in epilepsy patients receiving anti-epileptic drugs in a tertiary care teaching hospital
por: Pimpalkhute, Sonali A., et al.
Publicado: (2015)

A 12-week Comparative Prospective Open-label Randomized Controlled Study in Depression Patients Treated with Vilazodone and Escitalopram in a Tertiary Care Hospital in North India
por: Bathla, Manish, et al.
Publicado: (2018)

Role of zinc in pediatric diarrhea
por: Bajait, Chaitali, et al.
Publicado: (2011)

Authors’ reply
por: Bajait, Chaitali, et al.
Publicado: (2012)

A Prospective Observational Study on Changes in Intraocular Pressure and Iridocorneal Angle Following the Use of Escitalopram and Amitriptyline
por: Mandal, Shaswata, et al.
Publicado: (2022)

Comments on “A Prospective Observational Study on Changes in Intraocular Pressure and Iridocorneal Angle Following the Use of Escitalopram and Amitriptyline”
por: Mamtani, Nidhi, et al.
Publicado: (2023)

Vilazodone for the Treatment of Depression: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Response to the comments on “A Prospective Observational Study on Changes in Intraocular Pressure and Iridocorneal Angle Following the Use of Escitalopram and Amitriptyline”
por: Mandal, Shaswata, et al.
Publicado: (2023)

Comparison of efficacy, safety, and cost-effectiveness of sertaconazole and luliconazole cream in patients with dermatophytoses: A prospective, randomized, open-label study
por: Dakhale, Ganesh N., et al.
Publicado: (2021)

Comparison of Tolerance of Venlafaxine, Paroxetine and Amitriptyline in Depression Therapy
por: Miskovic, Mirjana
Publicado: (2015)

Vilazodone-Induced Hyperglycemia: A Case Series
por: Das, Abhipsa, et al.
Publicado: (2020)

Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
por: Gonzalez-Martinez, Alicia, et al.
Publicado: (2022)

Crystal structure of vilazodone hydrochloride methanol monosolvate
por: Hu, Xiu-Rong, et al.
Publicado: (2016)

A Review of Vilazodone, Serotonin, and Major Depressive Disorder
por: Pierz, Kerri A., et al.
Publicado: (2014)

The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
por: Plenge, Per, et al.
Publicado: (2021)

Effect of educational intervention on awareness of pharmacovigilance among medical undergraduates in a tertiary care teaching hospital
por: Kalikar, Mrunalini V., et al.
Publicado: (2020)

Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials
por: Shi, Ligen, et al.
Publicado: (2016)

Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
por: Thase, Michael E., et al.
Publicado: (2014)

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
por: Zhang, Xiao-Fei, et al.
Publicado: (2015)

The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
por: Sahli, Zeyad T., et al.
Publicado: (2016)

Randomized trial of vilazodone versus sertraline in depression: Concerns and comments
por: Praharaj, Samir Kumar
Publicado: (2021)

Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
por: Wade, Alan G, et al.
Publicado: (2011)

Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
por: Kalikar, Mrunalini V., et al.
Publicado: (2022)

Analysis of serious adverse events reports: Review by an Institutional Ethics Committee of a tertiary care teaching hospital
por: Dakhale, Ganesh Nathuji, et al.
Publicado: (2022)

Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression
por: Khan, Arif, et al.
Publicado: (2014)

Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice
por: Chauhan, Mohit, et al.
Publicado: (2022)

A Case of Amitriptyline-induced Myocarditis
por: Kassim, Thamer, et al.
Publicado: (2018)

The effect of antioxidants in acute amitriptyline poisoning
por: Kadar Ali, S. Hameed, et al.
Publicado: (2019)

Dermal delivery of amitriptyline for topical analgesia
por: Kung, Chin-Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l3mbuq1j90ie0gsilm1lj5grgk